HK$5.63
9.22%
Hong Kong, Nov 05, 04:08 pm HKT. Closed.
Why the stock moved Why the stock moved
ISIN
KYG8167W1380
Symbol
1177
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals

Sino Biopharmaceutical Stock News

Positive
Sino Biopharmaceutical
●
Reuters
●
4 months ago
Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs
Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China ​unit had secured rights to ‌market two respiratory drugs from British company GSK in mainland China.
Positive
Sino Biopharmaceutical
●
WSJ
●
4 months ago
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
Positive
Sino Biopharmaceutical
●
Reuters
●
4 months ago
Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion
Hong Kong-listed Sino Biopharmaceutical said on Wednesday it ​has granted AstraZeneca the ‌rights to develop a drug designed to treat chronic respiratory ​diseases outside China for ​total payments of up to $1.9 ⁠billion.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today